Qube Research & Technologies (QRT)
ELDN icon

Qube Research & Technologies (QRT)’s Eledon Pharmaceuticals ELDN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-175,891
Closed -$596K – 3640
2025
Q1 		$596K Buy
175,891
+53,750
+44% +$221K ﹤0.01% 2482
2024
Q4 		$503K Buy
+122,141
New +$482K ﹤0.01% 2473

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELDN Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Eledon Pharmaceuticals (ELDN) in Q2 2025, closing a stake of 175,891 shares — an estimated $596K sold.

Qube Research & Technologies (QRT) first reported a position in ELDN in Q4 2024 and held it in 2 quarters. The position peaked at $596K in Q1 2025. 85 funds tracked by Wall St. Rank hold ELDN as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Eledon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 175,891 Eledon Pharmaceuticals shares in Q2 2025, an estimated $596K.
  • Qube Research & Technologies (QRT) first reported a position in Eledon Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Eledon Pharmaceuticals position peaked at $596K in Q1 2025.
  • 85 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.